Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1988/004225external-prioritypatent/WO1989004873A1/en
Application filed by Univ North CarolinafiledCriticalUniv North Carolina
Publication of FI945110A0publicationCriticalpatent/FI945110A0/en
Publication of FI945110ApublicationCriticalpatent/FI945110A/en
Application grantedgrantedCritical
Publication of FI101936B1publicationCriticalpatent/FI101936B1/en
Publication of FI101936BpublicationCriticalpatent/FI101936B/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The present invention relates to a gene sequence, which codes protein I of Neisseria gonorrhoea, and cloning vector and host organisms contained therein. Also disclosed are oligonucleotides useful as diagnostic probes for the detection of N. gonorrhoea infection.
FI945110A1987-11-241994-10-31
Method for the preparation of gonorrhea vaccines
FI101936B
(en)
BACTERIA THAT HOST VECTOR OF EXPRESSION THAT CODES THE HUMAN CILIAR NEUROTROPHIC FACTOR (H-CNTF), ITS USE IN THE PRODUCTION OF H-CNTF, ANTIBODIES FOR H-CNTF AND THE USE OF H-CNTF IN MEDICAL TREATMENT.